DE3586853D1 - Immunologisch aktive peptide, geeignet zur einfuehrung von immunisierung gegen malaria und deren kodierung von genen. - Google Patents

Immunologisch aktive peptide, geeignet zur einfuehrung von immunisierung gegen malaria und deren kodierung von genen.

Info

Publication number
DE3586853D1
DE3586853D1 DE8585107794T DE3586853T DE3586853D1 DE 3586853 D1 DE3586853 D1 DE 3586853D1 DE 8585107794 T DE8585107794 T DE 8585107794T DE 3586853 T DE3586853 T DE 3586853T DE 3586853 D1 DE3586853 D1 DE 3586853D1
Authority
DE
Germany
Prior art keywords
genes
coding
introduction
immunologically active
active peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8585107794T
Other languages
English (en)
Other versions
DE3586853T2 (de
Inventor
Thomas Frank Mccutchan
John Barton Dame
Jackie Lester Williams
Imogene Schneider
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Commerce
Original Assignee
US Department of Commerce
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Commerce filed Critical US Department of Commerce
Publication of DE3586853D1 publication Critical patent/DE3586853D1/de
Application granted granted Critical
Publication of DE3586853T2 publication Critical patent/DE3586853T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/20—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
    • C07K16/205—Plasmodium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/29—Polyamino acid or polypeptide with an uninterrupted series of peptide repeating units

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE85107794T 1984-06-26 1985-06-24 Immunologisch aktive Peptide, geeignet zur Einführung von Immunisierung gegen Malaria und deren Kodierung von Genen. Expired - Lifetime DE3586853T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/624,564 US4707357A (en) 1984-06-26 1984-06-26 Immunologically active peptides capable of inducing immunization against malaria and genes encoding therefor

Publications (2)

Publication Number Publication Date
DE3586853D1 true DE3586853D1 (de) 1993-01-07
DE3586853T2 DE3586853T2 (de) 1993-10-07

Family

ID=24502471

Family Applications (1)

Application Number Title Priority Date Filing Date
DE85107794T Expired - Lifetime DE3586853T2 (de) 1984-06-26 1985-06-24 Immunologisch aktive Peptide, geeignet zur Einführung von Immunisierung gegen Malaria und deren Kodierung von Genen.

Country Status (9)

Country Link
US (1) US4707357A (de)
EP (1) EP0166410B1 (de)
JP (4) JP2561238B2 (de)
AU (1) AU596561B2 (de)
CA (1) CA1340431C (de)
DE (1) DE3586853T2 (de)
DK (2) DK166284C (de)
HK (1) HK1001823A1 (de)
ZA (1) ZA854697B (de)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2566780B1 (fr) * 1984-07-02 1987-02-06 Pasteur Institut Molecules comportant au moins une sequence peptidique porteuse d'un epitope caracteristique d'une proteine produite par des cellules infectees par les parasites du paludisme et compositions les contenant
ZA855232B (en) * 1984-07-23 1986-02-26 Univ New York Protective peptide antigen corresponding to plasmodium falciparum circumsporozoite protein
CN86100979A (zh) * 1985-02-07 1986-12-17 史密丝克莱恩贝克曼公司 疟疾疫苗的制备方法
NZ215023A (en) * 1985-02-07 1989-07-27 Smithkline Beckman Corp Vaccine against plasmodium falciparum and antigenic peptides
PT82282B (pt) * 1985-03-28 1988-02-17 Univ New York Processo de preparacao de um conjugado de proteina de suporte-antigeno imunogenico para uso como vacina contra malaria
ZW8386A1 (en) * 1985-04-11 1986-07-23 Inst Medical W & E Hall Highly repetitive antigens of plasmodium falciparum
EP0229829B1 (de) * 1985-07-12 1995-02-22 New York University Mit dem plasmodium-vivax-circumsporozoit-protein übereinstimmendes immunogenes peptidantigen
US4957869A (en) * 1985-07-12 1990-09-18 New York University Immunogenic peptide corresponding to P. vivax CS protein
IT1187710B (it) * 1985-07-25 1987-12-23 Eniricerche Spa Composizione peptidica utile per la preparazione di vaccini per la malaria e di kit diagnostici per la determinazione di affezioni malariche
EP0254862A1 (de) * 1986-06-26 1988-02-03 BEHRINGWERKE Aktiengesellschaft Impfstoffe gegen protozoischen Parasiten
US5019384A (en) * 1986-06-30 1991-05-28 Massachusetts Institute Of Technology Immunonodulating compositions and their use
IT1196501B (it) * 1986-07-16 1988-11-16 Eniricerche Spa Polipeptide utile per la preparazione di vaccini per la malaria e di kits diagnostici per la determinazione di affezioni malariche
US5225530A (en) * 1986-07-16 1993-07-06 Eniricerche S.P.A. Polypeptide useful for the preparation of antimalarial vaccines and of diagnostic kits for the detection of malarial affections
IT1198225B (it) * 1986-12-04 1988-12-21 Eniricerche Spa Polipeptidi immunologicamente attivi utili per la preparazione di vaccini antimalaria e di kits diagnostici per la determinazione di anticorpi antisporozoita
IT1198233B (it) * 1986-12-23 1988-12-21 Eniricerche Spa Metodo per la determinazione di anticorpi antisporozoita di p. falciparum nel sangue umano
US4957738A (en) * 1987-01-14 1990-09-18 Patarroyo Manuel E Protein copolymer malaria vaccine
EP0289110A3 (de) * 1987-02-02 1990-01-24 Swiss Serum and Vaccine Institute Berne Konjugierter Malaria-Impfstoff
FR2610631B1 (fr) * 1987-02-09 1989-11-24 Pasteur Institut Molecules comportant au moins une sequence peptidique porteuse d'un ou plusieurs, epitope caracteristique d'une proteine produite par p. falciparum dans les hepatocytes, et leurs utilisations, notamment pour le diagnostic du paludisme ou dans des compositions de vaccins contre le paludisme
IL85905A0 (en) * 1987-03-30 1988-09-30 Univ New York Immunogenic recombinant yeast expression product and method for purifying it
US5229490A (en) * 1987-05-06 1993-07-20 The Rockefeller University Multiple antigen peptide system
ATE118822T1 (de) * 1987-06-26 1995-03-15 Syntro Corp Rekombinanter, fremde gene enthaltender menschlicher cytomegalovirus und seine verwendung.
US5273876A (en) * 1987-06-26 1993-12-28 Syntro Corporation Recombinant human cytomegalovirus containing foreign gene
IT1223301B (it) * 1987-09-11 1990-09-19 Eniricerche Spa Polipeptidi sequenziali immunologicamente attivi
AT388934B (de) * 1987-11-13 1989-09-25 Wellcome Found Rekombinationskonjugatprotein und neue vakzinen
IT1233419B (it) * 1987-12-11 1992-03-31 Eniricerche Spa Peptidi sintetici immunologicamente attivi utili per la preparazione di un vaccino antimalaria
ATE139537T1 (de) * 1988-05-02 1996-07-15 Us Health Gen zum kodieren eines antigens gegen menschlichen malaria impfstoff
US5028425A (en) * 1988-07-07 1991-07-02 The United States Of America As Represented By The Department Of Health And Human Services Synthetic vaccine against P. falciparum malaria
GB8819209D0 (en) * 1988-08-12 1988-09-14 Research Corp Ltd Polypeptide & dna encoding same
US5231168A (en) * 1988-09-16 1993-07-27 Statens Seruminstitut Malaria antigen
JPH03504082A (ja) * 1988-12-21 1991-09-12 スミスクライン・バイオロジカルズ 昆虫細胞によるプラスモディウム属サーカムスポロゾイト蛋白の発現
ES2055785T3 (es) * 1989-01-17 1994-09-01 Eniricerche Spa Peptidos sinteticos y su uso como vehiculos universales para la preparacion de conjugados inmunogenos aptos para el desarrollo de vacunas sinteticas.
NZ233255A (en) * 1989-04-11 1993-02-25 Chiron Corp Plasmodium cs protein analogues lacking one or more of the repeat epitopes, and containing at least one nonrepeat flanking epitope
AU5649290A (en) * 1989-04-12 1990-11-05 New York University Dendritic polymer of multiple antigen peptide system useful as anti-malarial vaccine
CA2015722A1 (en) * 1989-05-03 1990-11-03 Mitchell S. Gross Malaria vaccine
IT1237764B (it) * 1989-11-10 1993-06-17 Eniricerche Spa Peptidi sintetici utili come carriers universali per la preparazione di coniugati immunogenici e loro impiego per lo sviluppo di vaccini sintetici.
AU7163091A (en) * 1989-12-12 1991-07-18 Biomedical Research Institute Novel malarial sporozoite peptide antigens
US5695957A (en) * 1990-02-05 1997-12-09 Imperial Exploitation Limited Polypeptides and DNA encoding same, associated with human malaria parasites
WO1991013161A1 (en) * 1990-02-22 1991-09-05 The United States Of America, Represented By The Secretary, United States Department Of Commerce Antigenic proteins of plasmodium
GB9015888D0 (en) * 1990-07-19 1990-09-05 Smithkline Biolog Vectors
US5095093A (en) * 1990-11-06 1992-03-10 The United States Of America As Represented By The Secretary Of The Navy Protective four amino acid epitope against Plasmodium vivax malaria
US6566121B1 (en) 1991-06-13 2003-05-20 Albert Einstein College Of Medicine Of Yeshiva University Insertional mutations in mycobacteria
US5786214A (en) * 1994-12-15 1998-07-28 Spinal Cord Society pH-sensitive immunoliposomes and method of gene delivery to the mammalian central nervous system
NO986133D0 (no) * 1998-12-23 1998-12-23 Preben Lexow FremgangsmÕte for DNA-sekvensering

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3033776A1 (de) * 1980-09-09 1982-04-22 Behringwerke Ag, 3550 Marburg Verfahren zur vermehrung von protozoen
US4554101A (en) * 1981-01-09 1985-11-19 New York Blood Center, Inc. Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity
US4466917A (en) * 1981-02-12 1984-08-21 New York University Malaria vaccine
GB2145092B (en) * 1983-01-28 1988-04-07 Univ New York Protective peptide antigen
US4767622A (en) * 1983-08-19 1988-08-30 University Of Illinois Method and materials for development of immunological responses protective against malarial infection
ZA855232B (en) * 1984-07-23 1986-02-26 Univ New York Protective peptide antigen corresponding to plasmodium falciparum circumsporozoite protein
ATE70308T1 (de) * 1984-09-12 1991-12-15 Chiron Corp Hybridpartikel-immunogene.
NZ215023A (en) * 1985-02-07 1989-07-27 Smithkline Beckman Corp Vaccine against plasmodium falciparum and antigenic peptides

Also Published As

Publication number Publication date
JP2561238B2 (ja) 1996-12-04
DK166284B (da) 1993-03-29
JPH07110876B2 (ja) 1995-11-29
JP2537027B2 (ja) 1996-09-25
DK289185A (da) 1985-12-27
HK1001823A1 (en) 1998-07-10
DK166155C (da) 1993-08-09
DK289185D0 (da) 1985-06-26
JPS61149093A (ja) 1986-07-07
CA1340431C (en) 1999-03-16
AU4399085A (en) 1986-01-02
ZA854697B (en) 1986-02-26
DK166284C (da) 1993-08-23
EP0166410A3 (en) 1987-11-25
JPH07265087A (ja) 1995-10-17
AU596561B2 (en) 1990-05-10
DK166155B (da) 1993-03-15
EP0166410A2 (de) 1986-01-02
EP0166410B1 (de) 1992-11-25
DK191991D0 (da) 1991-11-26
DE3586853T2 (de) 1993-10-07
JPH07265086A (ja) 1995-10-17
DK191991A (da) 1991-11-26
JP2537028B2 (ja) 1996-09-25
US4707357A (en) 1987-11-17
JPH06225768A (ja) 1994-08-16

Similar Documents

Publication Publication Date Title
DE3586853D1 (de) Immunologisch aktive peptide, geeignet zur einfuehrung von immunisierung gegen malaria und deren kodierung von genen.
DE3882593T2 (de) Polypeptid und dessen Herstellung.
DE3689246T2 (de) Physiologisch aktives Polypeptid BUF-3.
DE69032679T2 (de) Threo (2R, 3S)-3-amino-2-hydroxypentansäure und threo (2R,3S)-3-(p-methoxy-benzyloxycarbonyl/FMOC) amino-2-hydroxy-pentansäure
DE3786767D1 (de) Neues polypeptid.
DE3789413D1 (de) Lymphokin-ähnliche Peptide.
ES2107033T3 (es) Peptidos bpc, su preparacion y su utilizacion.
RU94041224A (ru) Пептиды с органозащитной активностью, фармацевтическая композиция на их основе и их применение в терапии
DE3685651D1 (de) Den antigenischen und immunogenischen determinanten von wichtigen neutralisierenden proteinen des rotavirus entsprechende peptide.
EP0129582A4 (de) Biologisch aktive peptide und proteine für orale verabreichung.
DE237398T1 (de) Verfahren zur herstellung biologisch aktiver polypeptide, so erhaltene polypeptide und diese enthaltende zusammensetzungen.
DE3682269D1 (de) Kautschukzusammensetzung sowie daraus hergestellte roehre und membranen.
DE3671231D1 (de) Cysteinreiche, gamma-glutaminsaeure-einheiten aufweisende peptide, verfahren zu deren herstellung und ihre verwendung.
DE3586765T2 (de) Immunogenische hav-peptide.
DE3877808D1 (de) Eisenoxidkatalysator und dessen herstellung.
DE3586940T2 (de) Polypeptid und dessen Verfahren zur Herstellung.
IT8323607A0 (it) Peptidi biologicamente attivi.
DE3585936D1 (de) Biologisch aktive peptide, deren verfahren zur herstellung und pharmazeutische zusammensetzungen.
DE3869939D1 (de) Biologisch wirksame peptide.
IT1214444B (it) Peptidi biologicamente attivi.
DE3782199D1 (de) Biologisch aktive peptide tan-866.
ATE75485T1 (de) Biologisch aktive peptide, deren verfahren zur herstellung und pharmazeutische zusammensetzungen.
DE69029259D1 (de) Polypeptid, dessen herstellung, und dieses polypeptid enthaltende pharmazeutische verbindungen und kosmetika
ATE92106T1 (de) Polypeptid und dessen herstellung.
ATE81531T1 (de) Biologisch aktive peptide tan-866.

Legal Events

Date Code Title Description
8332 No legal effect for de
8370 Indication related to discontinuation of the patent is to be deleted
8364 No opposition during term of opposition